EP3861012A4 - NUCLEASES GUIDED BY MODIFIED CHIMERIC NUCLEIC ACIDS, COMPOSITIONS, METHODS OF MAKING AND GENE EDITING SYSTEMS - Google Patents

NUCLEASES GUIDED BY MODIFIED CHIMERIC NUCLEIC ACIDS, COMPOSITIONS, METHODS OF MAKING AND GENE EDITING SYSTEMS Download PDF

Info

Publication number
EP3861012A4
EP3861012A4 EP19868458.1A EP19868458A EP3861012A4 EP 3861012 A4 EP3861012 A4 EP 3861012A4 EP 19868458 A EP19868458 A EP 19868458A EP 3861012 A4 EP3861012 A4 EP 3861012A4
Authority
EP
European Patent Office
Prior art keywords
nucleases
guided
compositions
making
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19868458.1A
Other languages
German (de)
French (fr)
Other versions
EP3861012A1 (en
Inventor
Ryan T. Gill
Rongming LIU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Colorado Denver
Original Assignee
University of Colorado System
University of Colorado Colorado Springs
University of Colorado Denver
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Colorado System, University of Colorado Colorado Springs, University of Colorado Denver filed Critical University of Colorado System
Publication of EP3861012A1 publication Critical patent/EP3861012A1/en
Publication of EP3861012A4 publication Critical patent/EP3861012A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19868458.1A 2018-10-04 2019-10-04 NUCLEASES GUIDED BY MODIFIED CHIMERIC NUCLEIC ACIDS, COMPOSITIONS, METHODS OF MAKING AND GENE EDITING SYSTEMS Withdrawn EP3861012A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862741470P 2018-10-04 2018-10-04
US201862741475P 2018-10-04 2018-10-04
PCT/US2019/054869 WO2020073005A1 (en) 2018-10-04 2019-10-04 Engineered chimeric nucleic acid guided nucleases, compositions, methods for making, and systems for gene editing

Publications (2)

Publication Number Publication Date
EP3861012A1 EP3861012A1 (en) 2021-08-11
EP3861012A4 true EP3861012A4 (en) 2022-10-19

Family

ID=70054911

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19868458.1A Withdrawn EP3861012A4 (en) 2018-10-04 2019-10-04 NUCLEASES GUIDED BY MODIFIED CHIMERIC NUCLEIC ACIDS, COMPOSITIONS, METHODS OF MAKING AND GENE EDITING SYSTEMS

Country Status (2)

Country Link
EP (1) EP3861012A4 (en)
WO (1) WO2020073005A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4093907A4 (en) * 2020-01-24 2024-01-17 The General Hospital Corporation METHODS FOR CHARACTERIZING ENZYMES FOR GENOMICS ENGINEERING

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017184768A1 (en) * 2016-04-19 2017-10-26 The Broad Institute Inc. Novel crispr enzymes and systems
WO2018071672A1 (en) * 2016-10-12 2018-04-19 The Regents Of The University Of Colorado Novel engineered and chimeric nucleases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017184768A1 (en) * 2016-04-19 2017-10-26 The Broad Institute Inc. Novel crispr enzymes and systems
WO2018071672A1 (en) * 2016-10-12 2018-04-19 The Regents Of The University Of Colorado Novel engineered and chimeric nucleases

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DAAN C. SWARTS ET AL: "Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a", MOLECULAR CELL, vol. 66, no. 2, 1 April 2017 (2017-04-01), AMSTERDAM, NL, pages 221 - 233, XP055569665, ISSN: 1097-2765, DOI: 10.1016/j.molcel.2017.03.016 *
DATABASE Geneseq [online] 31 May 2018 (2018-05-31), "Eubacterium rectale derived CpF1 nuclease, SEQ:2.", XP055925363, retrieved from EBI accession no. GSP:BFF09218 Database accession no. BFF09218 *
LINYI GAO ET AL: "Engineered Cpf1 variants with altered PAM specificities", NATURE BIOTECHNOLOGY, 5 June 2017 (2017-06-05), New York, XP055396069, ISSN: 1087-0156, DOI: 10.1038/nbt.3900 *
LIU R. M. ET AL: "Abstract", NATURE COMMUNICATIONS, vol. 10, no. 1, 1 December 2019 (2019-12-01), XP055785454, DOI: 10.1038/s41467-019-13500-y *
LUTZ S ET AL: "Creating multiple-crossover DNA libraries independent of sequence identity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 98, no. 20, 25 September 2001 (2001-09-25), pages 11248 - 11253, XP002250112, ISSN: 0027-8424, DOI: 10.1073/PNAS.201413698 *
See also references of WO2020073005A1 *

Also Published As

Publication number Publication date
EP3861012A1 (en) 2021-08-11
WO2020073005A1 (en) 2020-04-09

Similar Documents

Publication Publication Date Title
EP3701025A4 (en) NUCLEIC ACID TARGETED EDITING SYSTEMS, METHODS AND COMPOSITIONS
EP3692145A4 (en) NUCLEIC ACID TARGETED EDITING SYSTEMS, METHODS AND COMPOSITIONS
EP3701042A4 (en) NUCLEIC ACID TARGETED EDITING SYSTEMS, METHODS AND COMPOSITIONS
EP3684397A4 (en) SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED EDITION OF NUCLEIC ACIDS
IL284363A (en) RNA editing oligonucleotides for the treatment of Asher syndrome
IL282267A (en) DNA editing programmed by deaminase-nme2cas9 chimeric proteins
IL286324A (en) Methods and preparations for editing nucleotide sequences
EP3325665A4 (en) METHODS FOR AMPLIFYING NUCLEIC ACID SEQUENCES
IL286395A (en) Chemically modified oligonucleotides for rna editing
EP3864173C0 (en) SURFACE CAPTURE OF ACID MOLECULES FROM TARGET NUCLEIC INGREDIENTS
IL288794A (en) Constructs for target-directed genetic editing and methods for their use
SG11202008225PA (en) Novel rsv rna molecules and compositions for vaccination
IL282290A (en) Methods for introducing DNA into genes
EP3765608A4 (en) GENE CONTROL COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOTHERAPY
EP3596213A4 (en) GENE EXPRESSION AMPLIFICATION COMPOSITIONS AND METHODS
EP3728577A4 (en) PLANT GENE EDITING SYSTEMS, PROCEDURES AND COMPOSITIONS
EP3347714A4 (en) METHODS AND SYSTEMS FOR QUANTITATIVE MULTIPLEX AMPLIFICATION OF NUCLEIC ACIDS
EP3488016A4 (en) METHOD FOR AMPLIFYING NUCLEIC ACID SEQUENCES
WO2018218188A3 (en) Base editors with improved precision and specificity
EP3461274A4 (en) METHODS OF MULTIRESOLUTION ANALYSIS OF ACELLULAR NUCLEIC ACIDS
IL285842A (en) An improved process for dna incorporation using rna-directed endonucleases
IL284447A (en) Dux4 RNA silencing using crispr-cas13b targeted RNA
EP3390668A4 (en) METHODS OF DETERMINING THE NUMBER OF TUMOR GENE COPIES BY ACELLULAR DNA ANALYSIS
EP3765092A4 (en) GENE CONTROL COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOTHERAPY
IL285963A (en) Synthetic oncolytic replicon-lnp RNA and uses for cancer immunotherapy

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210407

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C40B 40/04 20060101ALI20220614BHEP

Ipc: C12N 15/113 20100101ALI20220614BHEP

Ipc: C12N 9/22 20060101ALI20220614BHEP

Ipc: C12N 15/11 20060101ALI20220614BHEP

Ipc: C12N 15/01 20060101ALI20220614BHEP

Ipc: C07K 14/195 20060101AFI20220614BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20220920

RIC1 Information provided on ipc code assigned before grant

Ipc: C40B 40/04 20060101ALI20220914BHEP

Ipc: C12N 15/113 20100101ALI20220914BHEP

Ipc: C12N 9/22 20060101ALI20220914BHEP

Ipc: C12N 15/11 20060101ALI20220914BHEP

Ipc: C12N 15/01 20060101ALI20220914BHEP

Ipc: C07K 14/195 20060101AFI20220914BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230421